ReviewFrontiers in immunology2023
Harnessing type I interferon-mediated immunity to target malignant brain tumors.
Juhee Lim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ReviewFrontiers in immunology2023
Juhee Lim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.